Download PDF
1 / Pages

Other users also viewed these articles

Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis Inês Leonor Leitão; Carla Mimoso Santos; Paulo André; Sara Lino; Marcos Lemos; Filipe Froes;
Enferm Infecc Microbiol Clin. 2023;41:454-61
Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa Lorena López-Cerero; Sofia Ballesta; Cristina Elías López; Waldo Sánchez-Yebra; María Dolores Rojo-Martin; Alvaro Pascual;
Enferm Infecc Microbiol Clin. 2023;41:621-4
Validation of MALDI-TOF for the early detection of the ST175 high-risk clone of Pseudomonas aeruginosa in clinical isolates belonging to a Spanish nationwide multicenter study Xavier Mulet; Marta Fernández-Esgueva; Cristina Norte; Laura Zamorano; Ester del Barrio-Tofiño; Antonio Oliver;
Enferm Infecc Microbiol Clin. 2021;39:279-82